An Open-Label, Randomized, Crossover Pharmacokinetic Study to Determine the Bioavailability, Safety and Tolerability of Single Doses of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat) in Patients With Refractory Epilepsy
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Diazepam (Primary) ; Diazepam
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Acorda Therapeutics
- 17 Feb 2017 Status changed from completed to discontinued.
- 25 Jul 2016 Status changed from active, no longer recruiting to completed.
- 10 Jun 2016 Planned End Date changed from 1 Nov 2016 to 1 Jul 2016.